After two decades of development, transcatheter left atrial appendage closure has emerged as a safe and effective intervention for stroke prevention in patients with atrial fibrillation. In 2024, significant advancements were made in the field of left atrial appendage closure in terms of evidence-based medicine, device research and development, and guideline consensus. The annual report on transcatheter left atrial appendage closure systematically reviews global academic progress in 2024, encompassing newly published clinical evidence, recently developed occlusion devices, and updated international guidelines/consensus statements. In the future, the development direction of transcatheter left atrial appendage closure mainly includes expanding surgical indications, optimizing imaging assistance technology, improving closure device design, and exploring individualized strategies for postoperative antithrombotic therapy.
Citation: BAI Yuan, ZHANG Xiaochun, ZENG Jie, WU Yongjian, ZHOU Daxin, Representatives of Structural Cardiology Committee of Cardiovascular Physicians Branch of Chinese Medical Doctor Association, National Clinical Research Center for Interventional Medicine, China Heart House. Annual report on transcatheter left atrial appendage closure in 2024. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2025, 32(6): 746-751. doi: 10.7507/1007-4848.202503024 Copy
Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved
-
Previous Article
Interpretation of "Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: Recommendations from the International Association for the Study of Lung Cancer Pathology Committee" -
Next Article
Interpretation of the CONSORT 2025 statement: Updated guideline for reporting randomized trials